YU43256B - Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one - Google Patents

Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one

Info

Publication number
YU43256B
YU43256B YU525/82A YU52582A YU43256B YU 43256 B YU43256 B YU 43256B YU 525/82 A YU525/82 A YU 525/82A YU 52582 A YU52582 A YU 52582A YU 43256 B YU43256 B YU 43256B
Authority
YU
Yugoslavia
Prior art keywords
piperazinylalkyl
phenoxyalkyl
subst
triazole
producing
Prior art date
Application number
YU525/82A
Other languages
English (en)
Other versions
YU52582A (en
Inventor
L Temple
Davis, Jr
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22922879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU43256(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of YU52582A publication Critical patent/YU52582A/xx
Publication of YU43256B publication Critical patent/YU43256B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU525/82A 1981-03-16 1982-03-11 Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one YU43256B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/244,464 US4338317A (en) 1981-03-16 1981-03-16 Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Publications (2)

Publication Number Publication Date
YU52582A YU52582A (en) 1985-06-30
YU43256B true YU43256B (en) 1989-06-30

Family

ID=22922879

Family Applications (1)

Application Number Title Priority Date Filing Date
YU525/82A YU43256B (en) 1981-03-16 1982-03-11 Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one

Country Status (26)

Country Link
US (1) US4338317A (es)
JP (1) JPS57159774A (es)
KR (1) KR880001374B1 (es)
AT (1) AT384022B (es)
BE (1) BE892503A (es)
CA (1) CA1198436A (es)
CH (1) CH649539A5 (es)
CY (1) CY1373A (es)
DE (1) DE3209557A1 (es)
DK (1) DK158728C (es)
ES (1) ES8305756A1 (es)
FI (1) FI73670C (es)
FR (1) FR2501690B1 (es)
GB (1) GB2096137B (es)
GR (1) GR76076B (es)
HK (1) HK4788A (es)
IE (1) IE52788B1 (es)
IT (1) IT1148137B (es)
KE (1) KE3711A (es)
LU (1) LU84011A1 (es)
MX (1) MX9203176A (es)
NL (2) NL190757C (es)
SE (1) SE447256B (es)
SG (1) SG30287G (es)
YU (1) YU43256B (es)
ZA (1) ZA821359B (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
AT388555B (de) * 1983-06-29 1989-07-25 Bristol Myers Co Verfahren zur herstellung von neuen 1,2,4-triazol-3-on-derivaten
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
EP0769297A1 (en) 1995-10-17 1997-04-23 Bristol-Myers Squibb Company Use of nefazodone for the manufacture of a medicament for the treatment of panic attack
CA2182241C (en) * 1996-07-29 2002-09-17 Bo Lei Methods for the manufacture of nefazodone
US5854248A (en) * 1996-07-31 1998-12-29 Bristol-Myers Squibb Company Nefazodone: use in migraine prophylaxis
US5852020A (en) * 1996-11-22 1998-12-22 Bristol-Myers Squibb Company Nefazodone: use in treating post traumatic stress disorder
US5735873A (en) * 1996-12-19 1998-04-07 Maclean; David S. Surgical tool handle
US5917050A (en) * 1998-02-11 1999-06-29 Bayer Corporation Process for preparing alkoxytriazolinones
ES2152860B1 (es) 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US6706282B1 (en) 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
JP2002541191A (ja) * 1999-04-09 2002-12-03 セプラコール， インク． Ｒ−ヒドロキシネファゾドン
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
EP1189616A2 (en) * 1999-04-09 2002-03-27 Sepracor Inc. S-hydroxynefazodone
CA2356450C (en) 2001-09-10 2003-11-25 Brantford Chemicals Inc. An improved process for the preparation of nefazodone hydrochloride
WO2003099265A2 (de) * 2002-05-24 2003-12-04 Coester Carl-Fr Pharmazeutische wirkstoffkombination sowie deren verwendung
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
WO2004098283A2 (en) * 2003-04-30 2004-11-18 Fmc Corporation Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
US7671072B2 (en) * 2003-11-26 2010-03-02 Pfizer Inc. Aminopyrazole derivatives as GSK-3 inhibitors
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
TW200612961A (en) * 2004-05-18 2006-05-01 Fmc Corp Substituted cyclic urea derivatives
CA2614289A1 (en) 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
AU2008204800A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
EP2183227B1 (en) * 2007-08-07 2014-09-24 Prosarix Limited 1,2,4-triazole derivatives as serotonergic modulators
US9339500B2 (en) 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
TWI368512B (en) * 2009-04-30 2012-07-21 Univ Kaohsiung Medical Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
CN104402842A (zh) * 2014-11-19 2015-03-11 苏州乔纳森新材料科技有限公司 一种哌嗪类药物中间体的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione

Also Published As

Publication number Publication date
ZA821359B (en) 1983-01-26
AT384022B (de) 1987-09-25
FR2501690A1 (fr) 1982-09-17
GB2096137B (en) 1985-01-03
AU8117082A (en) 1982-09-23
IT1148137B (it) 1986-11-26
DE3209557C2 (es) 1993-07-15
NL970014I2 (nl) 1997-09-01
IE52788B1 (en) 1988-03-02
ES510449A0 (es) 1983-04-16
FR2501690B1 (fr) 1985-07-05
US4338317A (en) 1982-07-06
AU555888B2 (en) 1986-10-16
DK112582A (da) 1982-09-17
CH649539A5 (de) 1985-05-31
IT8247978A0 (it) 1982-03-12
GB2096137A (en) 1982-10-13
NL970014I1 (nl) 1997-06-02
DK158728C (da) 1990-12-03
ATA104582A (de) 1987-02-15
JPS57159774A (en) 1982-10-01
JPH0237353B2 (es) 1990-08-23
FI820856L (fi) 1982-09-17
IE820589L (en) 1982-09-16
KR830009089A (ko) 1983-12-17
ES8305756A1 (es) 1983-04-16
DK158728B (da) 1990-07-09
NL190757C (nl) 1994-08-01
DE3209557A1 (de) 1982-12-09
FI73670C (fi) 1987-11-09
YU52582A (en) 1985-06-30
KR880001374B1 (ko) 1988-07-29
NL8201021A (nl) 1982-10-18
HK4788A (en) 1988-01-29
FI73670B (fi) 1987-07-31
CY1373A (en) 1987-08-07
BE892503A (fr) 1982-09-15
NL190757B (nl) 1994-03-01
KE3711A (en) 1987-04-30
CA1198436A (en) 1985-12-24
GR76076B (es) 1984-08-03
SE447256B (sv) 1986-11-03
SG30287G (en) 1987-07-17
MX9203176A (es) 1992-07-01
LU84011A1 (fr) 1983-02-22
SE8201631L (sv) 1982-09-17

Similar Documents

Publication Publication Date Title
YU52582A (en) Process for producing subst.2-or 4-(phenoxylkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one
PH17914A (en) Process for the production of new optically active 1,4-dihydropyridine compounds
PL239279A1 (en) Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines
YU227682A (en) Process for producing n-(4-(3-aminopropyl)-aminobutyl)-2-omega-guanidino-fatty acid-amindo)-2-subst.ethaneamide
DE3263757D1 (en) Process for preparing 1,2-dihydro-6-methyl-2-oxo-5-(pyridinyl)nicotinonitriles
AU520715B2 (en) PROCESS FOR PRODUCING (d. 1)-5-METHYL-TETRAHYDROFOLIC ACID
YU100381A (en) Process for producing antiinflammatory 4,5-diaryl-alpha-(polyfluoralkyl)-1h-pyrrol-2-metamines
DE3272222D1 (en) Process for producing 4-hydroxy-2,4,6,-trimethylcyclohexa-2,5-diene-1-one
ZA813111B (en) Process for producing 2,3,5-trichloropyridine
SU913942A3 (en) Process for producing 2,4-diamino-6-pyperidinopyrimidine-3-oxy (its modifications)
PT73016B (en) Process for preparing novel substituted pyrazinyl-1,2,4-oxidiazoles
YU155383A (en) Process for preparing 7,16-dioxa-2-aza-10-0-cladinosyl-12,0-desosaminyl-4,5-dihydroxy-6-ethy-3,5,9,11,13,15-hexamethyl-bicyclo(11.2.1)hexadeca-1(2)-ene-8-one
IE800777L (en) Producing 4-(pyridyl-2-oxy)phenoxy-alkanecarboxylic acid¹derivatives.
AU528874B2 (en) A process for the preparation of 1,5-dimethylbicyclo (3.2.1) octanol-8
YU43628B (en) Process for producing 2- or 2,6-substituted penem compounds
JPS6450870A (en) Novel process for manufacturing 1,2,4-triazole-3-one
AU544794B2 (en) 4-(2,2-dialkyl-indane-1-ylidene)-piperidines
YU181084A (en) Process for making 1,1-dioxopenicilano-iloxim ethyl-6-(2-amino-2-phenylacetamido) penicilanate
DE3267778D1 (en) Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxy-ethoxy-benzyl)-pyrimidine
IT8121861V0 (it) Dispositivo di chiusura simultanea dei due vani di una pressa per laproduzione di pannelli truciolari o fibrosi di legno o suoi succedanei.
GB2015517B (en) Process for producing 3,5-dichloro- - methylstyrene
DE3161613D1 (en) Process for the production of 3-mercapto-propanediol-(1,2)
YU284181A (en) Process for obtaining 2,3-dihydro-pyrane
YU225981A (en) Process for obtaining pharmaceutically active 4-(2-hydroxy-4-(subst.)phenyl)naphthalene-2-one
YU192682A (en) Process for obtaining new 1,2,3-thiadiazole-5-yl-carbamides